What happens to microglial TREM2 in Alzheimer’s disease: Immunoregulatory turned into immunopathogenic?

Abduljaleel, 2014, Evidence of trem2 variant associated with triple risk of Alzheimer’s disease, PLoS One, 9, e92648, 10.1371/journal.pone.0092648

Bakker, 1999, Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells, Proc Natl Acad Sci USA, 96, 9792, 10.1073/pnas.96.17.9792

Bessis, 2007, Microglial control of neuronal death and synaptic properties, Glia, 55, 233, 10.1002/glia.20459

Blasius, 2006, Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12, Blood, 107, 2474, 10.1182/blood-2005-09-3746

Bouchon, 2000, Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes, J Immunol, 164, 4991, 10.4049/jimmunol.164.10.4991

Bouchon, 2001, A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells, J Exp Med, 194, 1111, 10.1084/jem.194.8.1111

Boutajangout, 2013, The innate immune system in Alzheimer’s disease, Int J Cell Biol, 2013, 576383, 10.1155/2013/576383

Cady, 2014, TREM2 variant p. R47H as a risk factor for sporadic amyotrophic lateral sclerosis, JAMA Neurol, 71, 449, 10.1001/jamaneurol.2013.6237

Cantoni, 1999, NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily, J Exp Med, 189, 787, 10.1084/jem.189.5.787

Chertoff, 2013, Differential modulation of TREM2 protein during postnatal brain development in mice, PLoS One, 8, e72083, 10.1371/journal.pone.0072083

Colonna, 2007, The enigmatic function of TREM-2 in osteoclastogenesis, Adv Exp Med Biol, 602, 97, 10.1007/978-0-387-72009-8_13

Cuyvers, 2013, Investigating the role of rare heterozygous TREM2 variants in Alzheimer’s disease and frontotemporal dementia, Neurobiol Aging, 10

Daws, 2003, Pattern recognition by TREM-2: binding of anionic ligands, J Immunol, 171, 594, 10.4049/jimmunol.171.2.594

Dietrich, 2000, Cutting edge: signal-regulatory protein beta 1 is a DAP12-associated activating receptor expressed in myeloid cells, J Immunol, 164, 9, 10.4049/jimmunol.164.1.9

Forabosco, 2013, Insights into TREM2 biology by network analysis of human brain gene expression data, Neurobiol Aging, 34, 2699, 10.1016/j.neurobiolaging.2013.05.001

Ford, 2009, TREM and TREM-like receptors in inflammation and disease, Curr Opin Immunol, 21, 38, 10.1016/j.coi.2009.01.009

Frank, 2008, TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice, Glia, 56, 1438, 10.1002/glia.20710

Giraldo, 2013, Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer’s disease, Neurobiol Aging, 34, 2077, 10.1016/j.neurobiolaging.2013.02.016

Golde, 2013, Alzheimer’s disease risk alleles in TREM2 illuminate innate immunity in Alzheimer’s disease, Alzheimers Res Ther, 5, 24, 10.1186/alzrt178

Gosselin, 1999, Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H, J Leukoc Biol, 66, 165, 10.1002/jlb.66.1.165

Groves, 2008, Molecular mechanisms of phagocytic uptake in mammalian cells, Cell Mol Life Sci, 65, 1957, 10.1007/s00018-008-7578-4

Guerreiro, 2013, Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family, Neurobiol Aging, 34, 2890, 10.1016/j.neurobiolaging.2013.06.005

Guerreiro, 2013, TREM2 variants in Alzheimer’s disease, N Engl J Med, 368, 117, 10.1056/NEJMoa1211851

Guerreiro, 2013, Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement, JAMA Neurol, 70, 78, 10.1001/jamaneurol.2013.579

Hamerman, 2006, Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12, J Immunol, 177, 2051, 10.4049/jimmunol.177.4.2051

Hamerman, 2009, The expanding roles of ITAM adapters FcRgamma and DAP12 in myeloid cells, Immunol Rev, 232, 42, 10.1111/j.1600-065X.2009.00841.x

Hickman, 2013, TREM2 and the neuroimmunology of Alzheimer’s disease, Biochem Pharmacol

Hsieh, 2009, A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia, J Neurochem, 109, 1144, 10.1111/j.1471-4159.2009.06042.x

Humphrey, 2006, TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function, J Bone Miner Res, 21, 237, 10.1359/JBMR.051016

Ito, 2012, TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells, Eur J Immunol, 42, 176, 10.1002/eji.201141679

Jiang, 2014, Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer’s disease, Neuropsychopharmacology, 10.1038/npp.2014.164

Jin, 2014, Coding variants in TREM2 increase risk for Alzheimer’s disease, Hum Mol Genet, 10.1093/hmg/ddu277

Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer’s disease, N Engl J Med, 368, 107, 10.1056/NEJMoa1211103

Kaifu, 2003, Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice, J Clin Invest, 111, 323, 10.1172/JCI16923

Kiialainen, 2005, Dap12 and Trem2, molecules involved in innate immunity and neurodegeneration, are co-expressed in the CNS, Neurobiol Dis, 18, 314, 10.1016/j.nbd.2004.09.007

Kleinberger, 2014, TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis, Sci Transl Med, 6, 243ra86, 10.1126/scitranslmed.3009093

Klunemann, 2005, The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2, Neurology, 64, 1502, 10.1212/01.WNL.0000160304.00003.CA

Kondo, 2002, Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms, Neurology, 59, 1105, 10.1212/WNL.59.7.1105

Kreutzberg, 1996, Microglia :a sensor for pathological events in the CNS, Trends Neurosci, 19, 312, 10.1016/0166-2236(96)10049-7

Kuroda, 2007, A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease, J Neurol Sci, 252, 88, 10.1016/j.jns.2006.09.019

Lanier, 1998, Association of DAP12 with activating CD94/NKG2C NK cell receptors, Immunity, 8, 693, 10.1016/S1074-7613(00)80574-9

Lanier, 1998, Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells, Nature, 391, 703, 10.1038/35642

Le Ber, 2014, Homozygous TREM2 mutation in a family with atypical frontotemporal dementia, Neurobiol Aging, 35, 2419-5, 10.1016/j.neurobiolaging.2014.04.010

Lichtenthaler, 2011, Regulated intramembrane proteolysis–lessons from amyloid precursor protein processing, J Neurochem, 117, 779, 10.1111/j.1471-4159.2011.07248.x

Linnartz, 2010, Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation, Int J Alzheimers Dis, 10.4061/2010/587463

Lue, 2010, Microglia activation and anti-inflammatory regulation in Alzheimer’s disease, Mol Neurobiol, 41, 115, 10.1007/s12035-010-8106-8

Lue, 2014, TREM2 protein expression changes correlate with Alzheimer’s disease neurodegenerative pathologies in postmortem temporal cortices, Brain Pathol

Melchior, 2010, Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer’s disease, ASN Neuro, 2, e00037, 10.1042/AN20100010

Melchior, 2006, Microglia and the control of autoreactive T cell responses, Neurochem Int, 49, 145, 10.1016/j.neuint.2006.04.002

Miyamoto, 2013, Microglia and synapse interactions: fine tuning neural circuits and candidate molecules, Front Cell Neurosci, 7, 70, 10.3389/fncel.2013.00070

N’Diaye, 2009, TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria, J Cell Biol, 184, 215, 10.1083/jcb.200808080

Neumann, 2007, Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis, J Neuroimmunol, 184, 92, 10.1016/j.jneuroim.2006.11.032

O’Connor, 2008, The evolving role of semaphorins and plexins in the immune system: Plexin-A1 regulation of dendritic cell function, Immunol Res, 41, 217, 10.1007/s12026-008-8026-0

O’Neill, 2011, Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy, Immunity, 35, 746, 10.1016/j.immuni.2011.10.011

Paloneva, 2001, CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts, Neurology, 56, 1552, 10.1212/WNL.56.11.1552

Paloneva, 2000, Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts, Nat Genet, 25, 357, 10.1038/77153

Paloneva, 2002, Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype, Am J Hum Genet, 71, 656, 10.1086/342259

Paresce, 1996, Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor, Neuron, 17, 553, 10.1016/S0896-6273(00)80187-7

Peng, 2010, TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1, Sci Signal, 3, ra38, 10.1126/scisignal.2000500

Piccio, 2008, Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation, Brain, 131, 3081, 10.1093/brain/awn217

Piccio, 2007, Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis, Eur J Immunol, 37, 1290, 10.1002/eji.200636837

Prada, 2006, Triggering receptor expressed in myeloid cells 2 (TREM2) trafficking in microglial cells: continuous shuttling to and from the plasma membrane regulated by cell stimulation, Neuroscience, 140, 1139, 10.1016/j.neuroscience.2006.03.058

Qian, 1997, T cell antigen receptor signal transduction, Curr Opin Cell Biol, 9, 205, 10.1016/S0955-0674(97)80064-6

Rayaprolu, 2013, TREM2 in neurodegeneration: evidence for association of the p. R47H variant with frontotemporal dementia and Parkinson’s disease, Mol Neurodegen, 8, 19, 10.1186/1750-1326-8-19

Roumier, 2004, Impaired synaptic function in the microglial KARAP/DAP12-deficient mouse, J Neurosci, 24, 11421, 10.1523/JNEUROSCI.2251-04.2004

Roumier, 2008, Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function, PLoS One, 3, e2595, 10.1371/journal.pone.0002595

Sannerud, 2009, Trafficking, a key player in regulated intramembrane proteolysis, Semin Cell Dev Biol, 20, 183, 10.1016/j.semcdb.2008.11.004

Schmid, 2009, Differential gene expression in LPS/IFN gamma activated microglia and macrophages: in vitro versus in vivo, J Neurochem, 109, 117, 10.1111/j.1471-4159.2009.05984.x

Schmid, 2002, Heterogeneous expression of the triggering receptor expressed on myeloid cells-2 on adult murine microglia, J Neurochem, 83, 1309, 10.1046/j.1471-4159.2002.01243.x

Sessa, 2004, Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy dementia, Eur J Neurosci, 20, 2617, 10.1111/j.1460-9568.2004.03729.x

Sieber, 2013, Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke, PLoS One, 8, e52982, 10.1371/journal.pone.0052982

Stefano, 2009, The surface-exposed chaperone, Hsp60, is an agonist of the microglial TREM2 receptor, J Neurochem, 110, 284, 10.1111/j.1471-4159.2009.06130.x

Tahara, 2006, Role of toll-like receptor signalling in Abeta uptake and clearance, Brain, 129, 3006, 10.1093/brain/awl249

Takahashi, 2007, TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis, PLoS Med, 4, e124, 10.1371/journal.pmed.0040124

Takahashi, 2005, Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2, J Exp Med, 201, 647, 10.1084/jem.20041611

Takegahara, 2006, Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis, Nat Cell Biol, 8, 615, 10.1038/ncb1416

Thrash, 2009, Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease, Neurochem Res, 34, 38, 10.1007/s11064-008-9657-1

Turnbull, 2006, Cutting edge: TREM-2 attenuates macrophage activation, J Immunol, 177, 3520, 10.4049/jimmunol.177.6.3520

Ulrich, 2014, Altered microglial response to Abeta plaques in APPPS1-21 mice heterozygous for TREM2, Mol Neurodegen, 9, 20, 10.1186/1750-1326-9-20

Wake, 2011, Functions of microglia in the central nervous system–beyond the immune response, Neuron Glia Biol, 7, 47, 10.1017/S1740925X12000063

Wakselman, 2008, Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor, J Neurosci, 28, 8138, 10.1523/JNEUROSCI.1006-08.2008

Whittaker, 2010, The linker for activation of B cells (LAB)/non-T cell activation linker (NTAL) regulates triggering receptor expressed on myeloid cells (TREM)-2 signaling and macrophage inflammatory responses independently of the linker for activation of T cells, J Biol Chem, 285, 2976, 10.1074/jbc.M109.038398

Wu, 2000, DAP10 and DAP12 form distinct, but functionally cooperative, receptor complexes in natural killer cells, J Exp Med, 192, 1059, 10.1084/jem.192.7.1059

Wunderlich, 2013, Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and gamma-secretase-dependent intramembranous cleavage, J Biol Chem, 288, 33027, 10.1074/jbc.M113.517540

Yan, 2009, RAGE and Alzheimer’s disease: a progression factor for amyloid-beta-induced cellular perturbation?, J Alzheimers Dis, 16, 833, 10.3233/JAD-2009-1030

Yazawa, 2001, Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages, FASEB J, 15, 2454, 10.1096/fj.01-0251com

Ydens, 2012, Acute injury in the peripheral nervous system triggers an alternative macrophage response, J Neuroinflamm, 9, 176, 10.1186/1742-2094-9-176